ASCPT Membership

The American Society for Clinical Pharmacology and Therapeutics (ASCPT), founded in 1900, consists of over 2,300 professionals committed to promoting and advancing the science and practice of human pharmacology, translational medicine and therapeutics for the benefit of patients and society. The Society is the largest scientific and professional organization serving the discipline of clinical pharmacology and translational medicine. 

ASCPT members: 
Visit MyASCPT to find all of your membership resources and information. 

Interested in Joining?

Apply today! Start enjoying exclusive ASCPT member benefits!

Late-Breaking Membership News:
  • It is with great enthusiasm that ASCPT recently announced the launch of an Early Career membership category! Read this announcement from ASCPT President, Kellie S. Reynolds, PharmD, and join ASCPT today!
  • The 2018 dues renewal season has just kicked off! Renew early for your chance to win a complimentary registration to the ASCPT 2018 Annual Meeting. 
  • ASCPT is proud to recognize Andrea Leigh Hahn, MD for the July Member Spotlight.
  • Members only, take advantage of a Summer of Savings. For a limited time, ASCPT is waiving the $50 CPT submission fee. In addition, all submissions with an ASCPT member as the first, last, or corresponding author is guaranteed to undergo peer review. Ends August 31.
  • Visit the members-only Webinar LibraryPlease note you must be logged in as a member to access this content
  • ASCPT’s Online Career Center offers members-only, exclusive job post rates for the Summer months … Half Price 30-Day Premium Postings! Enter the coupon code 50PERCENT to take advantage of this discount. 

For access to past webinars please visit our new Webinar Library

Submit a Webinar Topic
Upcoming Webinar
SPO Webinar
Title: Modernization of Eligibility Criteria Initiative: Focus on Organ Impairment and Pediatrics Working Groups
Speakers: Atiqur Nam Rahman, PhD, Division Director and Ruby Leong, PhD, Reviewer, Office of Clinical Pharmacology, Center for Drug Evaluation and Research, Food and Drug Administration.
Moderators: Elimika Pfuma Fletcher, PharmD, PhD, and Catherine M.T. Sherwin, PhD
Date and Time: 11:00 AM, July 26, 2017
Description: Friends of Cancer Research (FOCR) and American Society of Clinical Oncology (ASCO) launched the Modernization of Eligibility Criteria Initiative in 2016. This is a collaborative effort with participants from FDA, NCI, patient advocates, pharmaceutical industry, academic and clinical investigators aimed to modernize eligibility criteria in order to promote patient participation in cancer clinical trials. The initiative began with four prioritized interdisciplinary working groups (WG): Minimum Age WG, Organ Impairment, Prior Malignancies and Comorbidities WG, Brain Metastases WG and HIV/AIDS WG. This webinar will focus on the inclusion of patients with organ dysfunction in trials and adolescent (12-18 years of age) patient’s inclusion in adult clinical trials based on recommendations from the Organ Dysfunction and Minimum Age WGs. Please see the recent article that discusses the impetus for the initiative to be discussed in this webinar. The speakers will discuss the data reviewed and the considerations behind the WG recommendations. 
Please visit the Special Populations site for registration.

528 N Washington St, Alexandria, VA 22314 |  Ph: 703.836.6981 |